Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

MLA

Azuma, Arata, et al. “Double-Blind, Placebo-Controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 9, May 2005, pp. 1040–47. EBSCOhost, https://doi.org/10.1164/rccm.200404-571OC.

APA

Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., Sato, A., & Kudoh, S. (2005). Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 171(9), 1040–1047. https://doi.org/10.1164/rccm.200404-571OC

Chicago

Azuma, Arata, Toshihiro Nukiwa, Eiyasu Tsuboi, Moritaka Suga, Shosaku Abe, Koichiro Nakata, Yoshio Taguchi, et al. 2005. “Double-Blind, Placebo-Controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.” American Journal of Respiratory and Critical Care Medicine 171 (9): 1040–47. doi:10.1164/rccm.200404-571OC.